Shiji Fang | Medicine | Best Researcher Award

Published on by Research Hypothesis

Best Researcher Award

Shiji Fang
Lishui Central Hospital, China

Shiji Fang
Affiliation Lishui Central Hospital
Country China
Scopus ID 57192204982
Documents 91
Citations 2,574
h-index 27
Subject Area Medicine
Event International Research Hypothesis Excellence Award
ORCID 0009-0004-4998-5039

Shiji Fang is a medical researcher affiliated with Lishui Central Hospital in China whose indexed research profile reflects sustained scholarly activity in biomedical and translational medicine. The available Scopus-derived profile records 91 documents, 2,574 citations and an h-index of 27, indicating a substantial body of indexed research and citation activity. [1][2]

Abstract

Shiji Fang’s research profile is situated within medicine and includes a substantial body of indexed scholarly work. The supplied publication record highlights research at the intersection of cancer biology, tumor microenvironment, immunotherapy and nanomedicine. Recent studies address mechanisms and therapeutic approaches involving immunogenic cell death, reactive oxygen species, endoplasmic reticulum stress, cellular senescence, copper homeostasis, ferroptosis, cuproptosis, chemoembolization and MRI-guided therapeutic systems. [1] [2]

Keywords

Shiji Fang; Best Researcher Award; Medicine; cancer research; hepatocellular carcinoma; immunotherapy; nanomedicine; immunogenic cell death; ferroptosis; cuproptosis; tumor biology; therapeutic delivery; translational medicine; oxidative stress; endoplasmic reticulum stress.

Introduction

Contemporary cancer research increasingly integrates molecular oncology with materials science, immunology and targeted therapeutic delivery. Hepatocellular carcinoma in particular presents a complex therapeutic environment in which tumor heterogeneity, immune suppression and resistance mechanisms can limit treatment effectiveness. Research that investigates interactions among tumor cells, immune pathways and therapeutic nanoplatforms therefore forms an important component of translational biomedical investigation.[2] [3]

Research Profile

The supplied Scopus profile identifies Shiji Fang with Author ID 57192204982 and lists Lishui Central Hospital, China, as the institutional affiliation. The profile is associated with the subject area of Medicine and records 91 indexed documents, 2,574 citations and an h-index of 27. [1]

Research characteristics

  • Primary discipline: Medicine.
  • Institutional affiliation: Lishui Central Hospital, China.
  • Scopus Author ID: 57192204982.
  • Indexed documents: 91.
  • Reported citations: 2,574.
  • Reported h-index: 27.
  • Major themes represented: cancer biology, hepatocellular carcinoma, immunotherapy, nanomedicine and regulated cell-death mechanisms.

Research Contributions

The supplied publications indicate several connected areas of research contribution. One strand examines how natural or bioactive compounds can influence cancer-cell death and stress-response pathways. The 2025 article on astragalin investigates immunogenic cell death in liver cancer in connection with NQO2, reactive oxygen species and endoplasmic reticulum stress. [2]

A second strand concerns the integration of cellular senescence with immune activation. The study published in Advanced Science describes a biomimetic nanomedicine approach designed around senescence-modulated immune activation and its potential relationship with immunotherapy efficacy in hepatocellular carcinoma. [3]

Publications

The following selected publications are taken from the supplied Scopus-derived research information. The list emphasizes recent 2025 articles and includes DOI identifiers where provided.

  1. Astragalin induces immunogenic cell death in liver cancer by targeting NQO2 to promote ROS-mediated endoplasmic reticulum stress pathway. Free Radical Biology and Medicine.
  2. Biomimetic Nanomedicine for Senescence-Modulated Immune Activation Enhances Immunotherapy Efficacy in Hepatocellular Carcinoma. Advanced Science.
  3. Cascade-targeting copper homeostasis nano-regulators for mild-photothermal boosted cuproptosis/ferroptosis mediated breast cancer therapy. Journal of Nanobiotechnology.
  4. Corrigendum to “Fangchinoline inhibits metastasis and reduces inflammation-induced epithelial-mesenchymal transition by targeting the FOXM1-ADAM17 axis in hepatocellular carcinoma”. Cellular Signalling.

Research Impact

The supplied bibliometric indicators provide a quantitative view of the visibility of the research record. With 2,574 reported citations and an h-index of 27 across 91 indexed documents, the profile demonstrates sustained citation activity within the indexed scholarly literature. [1] Bibliometric measures should nevertheless be interpreted alongside publication quality, methodological rigor, authorship contributions and the substantive influence of individual studies.

Award Suitability

The Best Researcher Award within the International Research Hypothesis Excellence Award framework can be assessed using evidence concerning research productivity, scholarly visibility, thematic contribution and relevance to the broader research community. The supplied profile provides several measurable indicators, including 91 indexed documents, 2,574 citations and an h-index of 27. [1]

Conclusion

Shiji Fang’s supplied academic profile presents an established research record in Medicine, with affiliation to Lishui Central Hospital in China and a Scopus Author ID of 57192204982. The reported 91 documents, 2,574 citations and h-index of 27 provide quantitative indicators of scholarly activity and citation visibility. [1]

References

  1. Elsevier. (n.d.). Scopus author details: Shiji Fang, Author ID 57192204982. Scopus.
    https://www.scopus.com/pages/authors/57192204982
  2. Zheng, L., Zhao, Z., Chen, L., Yang, W., Ercolani, G., Qin, P., Lin, B., Han, M., Weng, Q., Zhang, Y., et al. (2025). Astragalin induces immunogenic cell death in liver cancer by targeting NQO2 to promote ROS-mediated endoplasmic reticulum stress pathway. Free Radical Biology and Medicine.
    https://doi.org/10.1016/j.freeradbiomed.2025.07.047
  3. Fang, S., Zheng, L., Lin, B., Chen, J., Hou, D., Ding, Y., Han, M., Qin, P., Wang, M., Guo, X., et al. (2025). Biomimetic Nanomedicine for Senescence-Modulated Immune Activation Enhances Immunotherapy Efficacy in Hepatocellular Carcinoma. Advanced Science.
    https://doi.org/10.1002/advs.202517792
  4. Liang, X., Fang, S., Xin, Y., Lei, J., Wang, W., Wei, Y., Li, W., Li, C., Tang, H., Wei, X., et al. (2025). Cascade-targeting copper homeostasis nano-regulators for mild-photothermal boosted cuproptosis/ferroptosis mediated breast cancer therapy. Journal of Nanobiotechnology.
    https://doi.org/10.1186/s12951-025-03722-2
  5. Chen, M., Chen, Y., Chen, W., Chen, X., Guo, X., Yu, J., Guo, X., Wang, M., Zhang, X., Hu, Q., et al. (2025). Immune-activated microspheres for enhanced chemoembolization of hepatocellular carcinoma by blocking the adenosine A2A receptor. Acta Biomaterialia.
    https://doi.org/10.1016/j.actbio.2025.04.042
  6. Chen, X., Zhang, F., Lu, C., Wu, R., Yang, et al. (2025). Lactate-Fueled Theranostic Nanoplatforms for Enhanced MRI-Guided Ferroptosis Synergistic with Immunotherapy of Hepatocellular Carcinoma. ACS Applied Materials and Interfaces.
    https://doi.org/10.1021/acsami.4c21890

Quang Huynh Hong | Genetics and Genomics | Excellence in Research Award

Published on by Research Hypothesis

Prof. Dr. Quang Huynh Hong | Genetics and Genomics | Excellence in Research Award

Vice-director and Head | National Institute of Malariology Parasitology and Entomology | Vietnam

Prof. Dr. Quang Huynh Hong is a distinguished scholar and global health leader whose work has significantly advanced the fields of tropical medicine, parasitology, and infectious disease research. Recognized for his expertise in neglected and emerging parasitic diseases, he has played a pivotal role in malaria research, particularly in understanding drug resistance, molecular epidemiology, and treatment outcomes. His career is marked by excellence in research, teaching, and leadership, having guided multiple national and international projects that contribute to improved health systems and disease prevention strategies. As Vice-Director of a leading institute for parasitology and entomology, Prof. Dr. Quang Huynh Hong continues to shape the direction of scientific inquiry and public health advancements in Vietnam and beyond.

Professional Profile 

Education

Prof. Dr. Quang Huynh Hong holds an impressive academic background rooted in medicine and tropical disease specialization. He completed his foundational medical degree in Vietnam, furthering his expertise with advanced studies in tropical medicine in Thailand. His commitment to medical science led him to pursue a Master of Science in Medicine, which provided a strong foundation in clinical and epidemiological research. He later obtained his Doctorate in Medicine, focusing on parasitic diseases and malaria drug resistance, which remains the cornerstone of his scientific contributions. His international training and collaborations reflect his dedication to multidisciplinary learning and his ability to bridge medical knowledge across regions.

Experience

Over the course of his career, Prof. Dr. Quang Huynh Hong has held various leadership positions in research and academia. He currently serves as Vice-Director at the Institute of Malariology, Parasitology, and Entomology Quy Nhon, where he also heads the Clinical Epidemiology Research Unit. He has served as principal investigator and co-investigator in numerous national and international research projects supported by organizations such as the World Health Organization, the Wellcome Trust, and the Global Fund. His international influence is reflected in his joint appointments as a professor at Tokyo University, Taipei Medical University, Oxford University, and other prestigious institutions. In addition to his institutional responsibilities, he actively contributes to policy development, clinical guideline formation, and scientific training for young researchers and healthcare professionals.

Research Interest

Prof. Dr. Quang Huynh Hong’s research interests span a wide range of topics in global health and tropical medicine. His primary focus is on malaria, particularly in the context of drug resistance, molecular markers, and treatment efficacy. He is deeply engaged in parasitic zoonoses, neglected tropical diseases, and emerging infectious diseases that disproportionately affect vulnerable populations. His research integrates clinical investigations, laboratory-based molecular studies, and epidemiological analyses to address both local and global health challenges. He has also contributed to developing standard operating procedures for drug efficacy monitoring and diagnostic tools that are widely applied in health institutions across Southeast Asia. Through his “One Health” vision, he emphasizes the interconnectedness of human, animal, and environmental health, ensuring that his work has both scientific depth and societal impact.

Award

Prof. Dr. Quang Huynh Hong has been recognized for his remarkable achievements in research, teaching, and scientific leadership. His contributions to malaria drug resistance research and neglected tropical diseases have earned him recognition from academic and international health communities. He has played a leading role in advancing public health policies in Southeast Asia and has been invited as a visiting professor and speaker at several renowned global institutions. His dedication to mentoring young scientists, developing innovative research frameworks, and strengthening global partnerships positions him as an outstanding nominee for the International Research Hypothesis Excellence Award.

Selected Publication

  • “Molecular markers of antimalarial drug resistance in Plasmodium falciparum in Vietnam” (Published 2017, 125 Citations)

  • “Epidemiological profiling of neglected tropical diseases in Central Vietnam” (Published 2018, 94 Citations)

  • “Efficacy of artemisinin-based combination therapies for Plasmodium vivax and Plasmodium falciparum malaria” (Published 2019, 141 Citations)

  • “Zoonotic helminth infections and One Health perspectives in Southeast Asia” (Published 2020, 87 Citations)

Conclusion

Prof. Dr. Quang Huynh Hong stands out as a world-class researcher and academic leader whose lifelong dedication to parasitology, malaria research, and global health has made a profound impact. His academic achievements, leadership in international collaborations, and strong publication record reflect his excellence as both a scientist and a mentor. With his innovative approach to solving complex health challenges and his commitment to advancing medical science for the benefit of humanity, he represents the highest standard of academic and societal contribution. Prof. Dr. Quang Huynh Hong is an exceptional candidate whose career achievements and future potential fully justify his nomination for the International Research Hypothesis Excellence Award.